Healthcare

Kidney Disease Market Forecast 2024-2033: Growth Rate, Drivers, And Trends

The Kidney Disease Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Kidney Disease Market:

https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

According to The Business Research Company’s Kidney Disease Global Market Report 2024, The kidney disease market size has grown strongly in recent years. It will grow from $99.22 billion in 2023 to $106.6 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to rising chronic health conditions, aging population, genetic predisposition, medical research and education, environmental factors.

The kidney disease market size is expected to see strong growth in the next few years. It will grow to $136.97 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to global infectious disease management, precision medicine approaches, diabetes and obesity epidemic, healthcare policy changes, increased awareness and screening. Major trends in the forecast period include telemedicine for kidney care, focus on preventive nephrology, rise in home-based dialysis, regenerative therapies development, dietary modifications and nutrition.

The increased incidence of kidney diseases is expected to propel the growth of the kidney disease market going forward. Kidney diseases refer to a group of conditions that affect the function and structure of the kidneys. Kidney disorder medications are used to lower patients’ blood pressure and reduce protein loss, slowing the progression of kidney damage, managing symptoms, and preventing complications. For instance, in June 2023, according to Kidney Research UK, a UK-based charitable organization that conducts research and advocacy efforts to improve understanding, prevention, and treatment of kidney diseases, an estimated 7.19 million people in the UK were affected by chronic kidney disease in 2023, representing more than 10% of the UK population and projected to increase to 7.61 million people by 2033. Therefore, the increased incidence of kidney diseases is driving the growth of the kidney disease market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=11938&type=smp

The kidney disease market covered in this report is segmented –

1) By Treatment: Medication, Dialysis, Surgery, Other Treatments

2) By Indication: Acute Kidney Injury, Chronic Kidney Disease, End-Stage Renal Disease, Other Indication

3) By Route Of Administration: Oral, Parenteral

4) By End-User: Hospitals, Diagnostic Laboratories, Other End-Users

Integration of AI-driven tools is a key trend gaining popularity in the kidney disease market. Companies operating in the kidney disease market are adopting new technologies to facilitate improved patient outcomes and sustain their position in the market. For instance, in November 2022, Carenostics, a US-based healthcare startup specializing in AI solutions, launched its inaugural product designed to analyze electronic health record (EHR) data for the early identification of chronic kidney disease (CKD). Carenostics seamlessly integrates AI-powered clinical decision support models into healthcare providers’ electronic health record (EHR) systems. This integration empowers clinicians to accurately identify high-risk patients with chronic diseases, enabling them to take proactive measures for better patient outcomes.

The kidney disease market report table of contents includes: